Riunet Móvil

Home Versión de escritorio

Drugs for COVID-19: An Update

Mostrar el registro sencillo del ítem

dc.contributor.author Ceramella, Jessica es_ES
dc.contributor.author Iacopetta, Domenico es_ES
dc.contributor.author Sinicropi, Maria Stefania es_ES
dc.contributor.author Andreu, Inmaculada es_ES
dc.contributor.author Mariconda, Annaluisa es_ES
dc.contributor.author Saturnino, Carmela es_ES
dc.contributor.author Giuzio, Federica es_ES
dc.contributor.author Longo, Pasquale es_ES
dc.contributor.author Aquaro, Stefano es_ES
dc.contributor.author Catalano, Alessia es_ES
dc.date.accessioned 2023-05-30T18:00:59Z
dc.date.available 2023-05-30T18:00:59Z
dc.date.issued 2022-12 es_ES
dc.identifier.uri http://hdl.handle.net/10251/193740
dc.description.abstract [EN] The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was the seventh known human coronavirus, and it was identified in Wuhan, Hubei province, China, in 2020. It caused the highly contagious disease called coronavirus disease 2019 (COVID-19), declared a global pandemic by the World Health Organization (WHO) on 11 March 2020. A great number of studies in the search of new therapies and vaccines have been carried out in these three long years, producing a series of successes; however, the need for more effective vaccines, therapies and other solutions is still being pursued. This review represents a tracking shot of the current pharmacological therapies used for the treatment of COVID-19. es_ES
dc.description.sponsorship This work was supported by the Italian Ministry of University and Research (MUR, D.M.1062 del 10.08.2021)-PON R & I 2014-2020 Azione IV.6 "Contratti di Ricerca su Tematiche Green" 1062_R13_GREEN (J.C.); PRIN (Progetti di Rilevante Interesse Nazionale) Grant 2017M8R7N9_004 and 2020KSY3KL_005 from MUR, Italy (S.A.) and Project HORIZON EUROPE SEEDS ID S17 "Tutela della liberta e contrasto delle pandemie. Scienza e diritto per la definizione delle strategie per il contenimento delle situazioni di contagio"-NextgenerationEU Programma MUR-Fondo promozione e sviluppo-DM 737/2021 (A.C.). es_ES
dc.language Inglés es_ES
dc.publisher MDPI AG es_ES
dc.relation.ispartof Molecules es_ES
dc.rights Reconocimiento (by) es_ES
dc.subject Antibiotics es_ES
dc.subject Anticoagulants es_ES
dc.subject Antivirals es_ES
dc.subject COVID-19 es_ES
dc.subject Interleukin inhibitors es_ES
dc.subject JAKs inhibitors es_ES
dc.subject Immunomodulators es_ES
dc.subject NSAIDs es_ES
dc.subject SARS-CoV-2 es_ES
dc.subject.classification QUIMICA ORGANICA es_ES
dc.title Drugs for COVID-19: An Update es_ES
dc.type Artículo es_ES
dc.identifier.doi 10.3390/molecules27238562 es_ES
dc.relation.projectID info:eu-repo/grantAgreement/EC//DM 737%2F2021//Progetto ID S17: Tutela della libertà e contrasto delle pandemie. Scienza e diritto per la definizione delle strategie per il contenimento delle situazioni di contagio/ es_ES
dc.relation.projectID info:eu-repo/grantAgreement/MUR//1062_R13_GREEN/ es_ES
dc.relation.projectID info:eu-repo/grantAgreement/MUR//2017M8R7N9_004//Progetti di Rilevante Interesse Nazionale (PRIN)/ es_ES
dc.relation.projectID info:eu-repo/grantAgreement/MUR//2020KSY3KL_005//Progetti di Rilevante Interesse Nazionale (PRIN)/ es_ES
dc.rights.accessRights Abierto es_ES
dc.contributor.affiliation Universitat Politècnica de València. Escuela Técnica Superior de Ingenieros Industriales - Escola Tècnica Superior d'Enginyers Industrials es_ES
dc.description.bibliographicCitation Ceramella, J.; Iacopetta, D.; Sinicropi, MS.; Andreu, I.; Mariconda, A.; Saturnino, C.; Giuzio, F.... (2022). Drugs for COVID-19: An Update. Molecules. 27(23):1-17. https://doi.org/10.3390/molecules27238562 es_ES
dc.description.accrualMethod S es_ES
dc.relation.publisherversion https://doi.org/10.3390/molecules27238562 es_ES
dc.description.upvformatpinicio 1 es_ES
dc.description.upvformatpfin 17 es_ES
dc.type.version info:eu-repo/semantics/publishedVersion es_ES
dc.description.volume 27 es_ES
dc.description.issue 23 es_ES
dc.identifier.eissn 1420-3049 es_ES
dc.identifier.pmid 36500655 es_ES
dc.identifier.pmcid PMC9740261 es_ES
dc.relation.pasarela S\479762 es_ES
dc.contributor.funder European Commission es_ES
dc.contributor.funder Ministero dell'Università e della Ricerca es_ES
dc.relation.references 10.3390/v14030573 es_ES
dc.relation.references 10.1001/jama.2021.14811 es_ES
dc.relation.references 10.1101/2022.07.31.22278258 es_ES
dc.relation.references 10.1016/S1473-3099(22)00663-6 es_ES
dc.relation.references 10.3390/foods11182884 es_ES
dc.relation.references 10.1007/s12016-021-08848-3 es_ES
dc.relation.references 10.3390/biomedicines9111620 es_ES
dc.relation.references 10.3390/ph14080736 es_ES
dc.relation.references 10.3390/molecules27030616 es_ES
dc.relation.references 10.1056/NEJMp2204813 es_ES
dc.relation.references 10.1056/NEJMe2209017 es_ES
dc.relation.references 10.1002/jmv.25825 es_ES
dc.relation.references 10.1080/22221751.2020.1719902 es_ES
dc.relation.references 10.1126/science.abb2762 es_ES
dc.relation.references 10.1038/s41579-020-00468-6 es_ES
dc.relation.references 10.1016/j.cell.2020.02.052 es_ES
dc.relation.references 10.1016/j.bmc.2020.115860 es_ES
dc.relation.references 10.1208/s12248-020-00532-2 es_ES
dc.relation.references 10.1038/s41401-020-0485-4 es_ES
dc.relation.references 10.1038/s41598-022-07918-6 es_ES
dc.relation.references 10.3390/ijms23031351 es_ES
dc.relation.references 10.1038/s41586-020-2223-y es_ES
dc.relation.references 10.1021/acs.jmedchem.1c01307 es_ES
dc.relation.references 10.1016/j.biopha.2021.112517 es_ES
dc.relation.references 10.1016/j.ejphar.2021.173890 es_ES
dc.relation.references 10.1053/j.semnuclmed.2021.06.004 es_ES
dc.relation.references 10.1016/S0140-6736(22)00519-0 es_ES
dc.relation.references 10.3389/fphar.2021.683296 es_ES
dc.relation.references 10.1016/j.actatropica.2020.105778 es_ES
dc.relation.references 10.1007/s10096-021-04307-1 es_ES
dc.relation.references 10.1007/s40121-021-00517-4 es_ES
dc.relation.references 10.1038/s41598-022-08794-w es_ES
dc.relation.references 10.1038/s41598-021-90551-6 es_ES
dc.relation.references 10.1186/s12985-021-01526-y es_ES
dc.relation.references 10.1186/s41479-021-00092-9 es_ES
dc.relation.references 10.1056/NEJMoa2001282 es_ES
dc.relation.references 10.2217/fvl-2021-0066 es_ES
dc.relation.references 10.1371/journal.pone.0267884 es_ES
dc.relation.references 10.1007/s40272-022-00500-7 es_ES
dc.relation.references 10.1016/j.dsx.2021.102329 es_ES
dc.relation.references 10.12659/MSM.935952 es_ES
dc.relation.references 10.3390/ijms23031508 es_ES
dc.relation.references 10.1007/s40265-022-01684-5 es_ES
dc.relation.references 10.1016/j.antiviral.2022.105430 es_ES
dc.relation.references 10.1016/S0140-6736(22)01586-0 es_ES
dc.relation.references 10.1016/j.drup.2021.100794 es_ES
dc.relation.references 10.3390/antibiotics11020220 es_ES
dc.relation.references 10.1093/cid/ciac673 es_ES
dc.relation.references 10.1016/j.jinf.2022.09.027 es_ES
dc.relation.references 10.3389/fmed.2022.980002 es_ES
dc.relation.references 10.1021/acscentsci.0c01186 es_ES
dc.relation.references 10.1007/s00253-021-11094-4 es_ES
dc.relation.references 10.1016/j.biocel.2021.106114 es_ES
dc.relation.references 10.1590/s1677-5538.ibju.2020.s118 es_ES
dc.relation.references 10.1089/mdr.2020.0232 es_ES
dc.relation.references 10.1016/j.biopha.2020.111008 es_ES
dc.relation.references 10.1101/2022.01.11.22269069 es_ES
dc.relation.references 10.1080/14787210.2020.1813024 es_ES
dc.relation.references 10.1007/s40264-020-00976-7 es_ES
dc.relation.references 10.3389/fimmu.2021.574425 es_ES
dc.relation.references 10.1183/13993003.00752-2021 es_ES
dc.relation.references 10.1016/j.bjid.2021.101549 es_ES
dc.relation.references 10.3389/fphar.2021.659577 es_ES
dc.relation.references 10.7150/thno.49713 es_ES
dc.relation.references 10.1007/s11010-021-04325-9 es_ES
dc.relation.references 10.1016/j.ejim.2021.11.005 es_ES
dc.relation.references 10.1002/iid3.563 es_ES
dc.relation.references 10.1002/jcla.24434 es_ES
dc.relation.references 10.1007/s43440-020-00155-6 es_ES
dc.relation.references 10.1016/j.ejphar.2020.173644 es_ES
dc.relation.references 10.3390/ijms22063059 es_ES
dc.relation.references 10.1111/bcp.15124 es_ES
dc.relation.references 10.1002/jmv.27488 es_ES
dc.relation.references 10.1007/s10787-021-00903-x es_ES
dc.relation.references 10.1136/ejhpharm-2021-002741 es_ES
dc.relation.references 10.1101/2022.03.02.22271623 es_ES
dc.relation.references 10.1007/s15010-021-01730-6 es_ES
dc.relation.references 10.1007/s11033-021-06793-0 es_ES
dc.relation.references 10.1016/j.ejphar.2021.173854 es_ES
dc.relation.references 10.1007/s11739-021-02800-1 es_ES
dc.relation.references 10.1016/j.jvsv.2020.05.018 es_ES
dc.relation.references 10.3389/fmed.2021.615333 es_ES
dc.relation.references 10.1016/j.bioorg.2022.105663 es_ES
dc.relation.references 10.1016/j.eclinm.2022.101373 es_ES
dc.relation.references 10.1128/JVI.00014-21 es_ES
dc.relation.references 10.1007/s10238-020-00671-y es_ES
dc.relation.references 10.1002/mco2.151 es_ES
dc.relation.references 10.1021/acs.jmedchem.2c00624 es_ES
dc.relation.references 10.1021/acs.jmedchem.2c00117 es_ES
dc.relation.references 10.1021/acs.jmedchem.2c00178 es_ES
dc.relation.references 10.1016/j.celrep.2021.109839 es_ES
dc.relation.references 10.1021/acsbiomaterials.2c00510 es_ES
dc.relation.references 10.2147/DDDT.S367612 es_ES
dc.relation.references 10.1038/s41421-022-00450-x es_ES


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

 

Tema móvil para Riunet